Similar articles

• Intentional overdose with insulin glargine and insulin aspart.

  Tofade TS, Liles EA. Tofade TS, et al. Pharmacotherapy. 2004 Oct;24(10):1412-8. doi: 10.1592/phco.24.14.1412.43147. Pharmacotherapy. 2004. PMID: 15628838 Review.
• Lantus overdose: case presentation and management options.

  Fuller ET, Miller MA, Kaylor DW, Janke C. Fuller ET, et al. J Emerg Med. 2009 Jan;36(1):26-9. doi: 10.1016/j.jemermed.2007.02.038. Epub 2007 Jul 20. J Emerg Med. 2009. PMID: 17976762
• Prolonged glucose requirements after intentional glargine and aspart overdose.

  Fromont I, Benhaim D, Ottomani A, Valéro R, Molines L, Vialettes B. Fromont I, et al. Diabetes Metab. 2007 Nov;33(5):390-2. doi: 10.1016/j.diabet.2007.05.002. Epub 2007 Jul 20. Diabetes Metab. 2007. PMID: 17644447
• Poisoning with insulin glargine.

  Brvar M, Mozina M, Bunc M. Brvar M, et al. Clin Toxicol (Phila). 2005;43(3):219-20. Clin Toxicol (Phila). 2005. PMID: 15902802 No abstract available.
• Initiating basal insulin therapy in patients with type 2 diabetes mellitus.

  Stoneking K. Stoneking K. Am J Health Syst Pharm. 2005 Mar 1;62(5):510-8. doi: 10.1093/ajhp/62.5.510. Am J Health Syst Pharm. 2005. PMID: 15745915 Review. No abstract available.